They didn’t give Coons Over $200k for nothing
Insulin prices doubled between 2012 and 2016. In that period Coons pocketed over $200,000 in donations from big pharma. Probably just a coincidence.
Connect
Connect with us on the following social media platforms.
Doubled.
When Coons reaches across the aisle to make deals, it’s for the benefit of his corporate backers, not average Delawareans. There’s a REASON, after all, why he’s the Rethugs’ favorite senator. He’ll go along with what they want as long as he can sneak some language on behalf of his corporate benefactors into some bill.
Delaware’s 2017 diagnosed diabetes prevalence was slightly higher than that of the U.S. (11.3% vs 10.5%, respectively) (CDC, 2017). In 2017, over 85,400 Delawareans age 18 or older had diabetes; an additional 94,628 adults had prediabetes (DPH, 2018).
The American Diabetes Association (ADA) estimates that diabetes and prediabetes cost $1.1 billion in Delaware each year, reflecting $818 million in direct medical expenses and $293 million in indirect costs (ADA, 2018). In 2017, Delaware hospitals recorded 2,160 discharges due to diabetes (1.9% of all Delaware hospital discharges). From 2003 to 2017, Delaware’s hospitalization rate due to diabetes increased 24.2%, rising from 16.1 hospitalizations per 10,000 population to 20.0 hospitalizations per 10,000 population (DHSC, 2018). The 2017 average length of inpatient stay for diabetes with accompanying complications was 5.6 days, totaling an average per-patient charge of $28,684 (DHSC, 2018).
https://dhss.delaware.gov/dhss/dph/dpc/files/theimpactofdiabetesindelaware2019.pdf